Come up with a name for your new list and we'll add to it:
BioSyntagma raised a round of funding on December 08, 2016. Investors include
National Science Foundation.
bioSyntagma has developed a device that enables researchers and drug developers to interrogate samples at an unprecedented level, making personalized medicine a more imminent reality.…